| Sign In to gain access to subscriptions and/or personal tools. |
Institutional patterns of symptomatic medication in hospitalized patients with advanced cancerDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York Although standards for palliative treatment of cancer patients at end of life are available, their use is perceived to vary among institutions depending on the prevailing philosophy of care. In this retrospective study, we reviewed the treatment of dying cancer patients receiving intravenous morphine transferred from a cancer center to a palliative care hospital. We recorded the dose of morphine and the use of other palliative medications, including adjuvant analgesic drugs. Although morphine doses tended to decrease after the transfer, the use of palliative medications was similar in the two institutions.
Key Words: cancer analgesia morphine pain palliative care symptom management
American Journal of Hospice and Palliative Medicine®, Vol. 21, No. 2,
134-136 (2004) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||